Skip to main content

Gilead Sciences

Founded in 1987, Gilead Sciences is a public biopharmaceutical company headquartered in the United States. It develops and commercialises antiviral, oncology, and inflammatory disease medicines, used to prevent and treat diseases such as HIV, viral hepatitis, and cancer. Gilead Sciences is known for pioneering therapies such as Biktarvy and Veklury. Gilead Sciences is listed in the Fortune 500 and Forbes Global 2000.

North America
Pharmaceuticals & Biotechnology
Public
Not Engaged
Visit Website
ACT Core
C Inconsequential planning
Just Transition
0.0/100
Nature Benchmark
15.0/100
Social Benchmark
22.7/100
Gender Assessment
26.5/100
On this page

Subscribe to stay informed on our work

Keep up to date with all the latest from World Benchmarking Alliance

Join our newsletter